SCHEMBL32665245

SCHEMBL32665245

O=C(O)c1ccc(F)c(OS(=O)(=O)F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.49
RAB9A P51151 2/20 0.49
LMNA P02545 1/20 0.49
MAPK1 P28482 1/20 0.49
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA7 P43166 1/20 0.44
TPMT P51580 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
PTK2B Q14289 2/20 0.44
MRGPRX4 Q96LA9 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 2/20 0.42
GAA P10253 2/20 0.42
TSHR P16473 2/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665353 0.86 RAB9A (0.62) HTTRAB9ALMNAMAPK1CA12
SCHEMBL32665536 0.85 STS (0.41) HTTRAB9ALMNAMAPK1GAA
SCHEMBL32665602 0.81 GSK3B (0.46) MEN1KMT2A
SCHEMBL31448065 0.80 CA12 (0.69) HTTRAB9ALMNAMAPK1CA12
SCHEMBL16358344 0.78 HTT (0.55) HTTRAB9ALMNAMAPK1CA12
SCHEMBL156299 0.77 HTT (0.73) HTTRAB9ALMNAMAPK1CA12
SCHEMBL30307554 0.77 HTT (0.73) HTTRAB9ALMNAMAPK1CA12
SCHEMBL31448177 0.74 ALDH1A1 (0.53) HTTRAB9ALMNAMAPK1CA12
SCHEMBL6848357 0.74 ALDH1A1 (0.71) HTTRAB9ALMNAMAPK1CA12
SCHEMBL1110964 0.74 HTT (0.50) HTTRAB9ALMNAMAPK1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A HTT 4632/4885RAB9A 1980/4885LMNA 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.